Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)

Kalorama Information
January 1, 2012
160 Pages - SKU: KLI6490034
Stem Cell Therapeutics Markets
10/9/2014 | published by: Kalorama Information
Stem Cell Therapeutics Markets There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries,  |  read more...
USD 3,995
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014’, provides an overview of the Hormone-Sensitive Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Retinopathy Of Prematurity - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Retinopathy Of Prematurity - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Retinopathy Of Prematurity - Pipeline Review, H2 2014’, provides an overview of the Retinopathy Of Prematurity’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014’, provides an overview of the Nerve Gas & Pestiside Poisioning’s therapeutic pipeline. This report  |  read more...
USD 2,000
Premature Labor (Tocolysis) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Premature Labor (Tocolysis) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Premature Labor (Tocolysis) - Pipeline Review, H2 2014’, provides an overview of the Premature Labor (Tocolysis)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Parkinson's Disease - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Parkinson's Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H2 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Parkinson's  |  read more...
USD 2,500
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014’, provides an overview of the Acute Myelocytic Leukemia (AML,  |  read more...
USD 2,000
Psoriasis - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Psoriasis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Psoriasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Psoriasis, complete with comparative  |  read more...
USD 2,000
Stroke - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Stroke - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Stroke - Pipeline Review, H2 2014’, provides an overview of the Stroke’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Stroke, complete with comparative  |  read more...
USD 2,000
Non-Hodgkin Lymphoma - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Non-Hodgkin Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non-Hodgkin  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 1,995  
    Global Site License  USD 3,990  
    Departmental Site License (one location, 10 users)  USD 2,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!